Olufemi Bunmi Aina, MBBS

Olufemi Aina practices at U S Renal Care South Georgia Dialysis in Valdosta, Georgia.

Olufemi Aina's NPI, 1356690671, was assigned on August 31, 2012. Olufemi Aina holds Georgia license 078554.

Olufemi Aina's primary practice is U S Renal Care South Georgia Dialysis, at 2922 N Oak St, Valdosta, GA 31602 in Lowndes County. The practice phone is (229) 249-3222.

Olufemi Aina's primary practice is U S Renal Care South Georgia Dialysis in Valdosta, Georgia. Olufemi Aina is also affiliated with Northeast Georgia Medical Center Gainesville. The medical group on file is Apogee Medical Group Georgia. Dmand AI also links Olufemi Aina to 4 more hospitals, 3 dialysis centers, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Olufemi Aina practices, 10 sites in all. Vendor and product names are available with a free account.

Hospitalist is Olufemi Aina's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Olufemi Aina is licensed in Georgia.

CMS data shows 1,349 Medicare services from Olufemi Aina across 8 procedure codes in 2024, for 446 Medicare patients. Medicare paid $257,147 for them.

CMS counts 446 Medicare patients who saw Olufemi Aina in 2024. The largest group is 65 to 74, with 133 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 3.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Olufemi Aina's median patient age at 67, with 50% women.

In 2024, Olufemi Aina wrote 1,037 Medicare Part D claims for 125 patients. 86% of them were for generic drugs. CMS names the drug for 868 of them, across 22 drugs with 11 or more claims each, at $51,117 in total drug cost. In 2023, CMS named 1,011 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Olufemi Aina for performance year 2024, reported as part of a group. Olufemi Aina accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Olufemi Aina, published from 2015 to 2017. Olufemi Aina's most frequent co-authors are Chidozie Agu, MD, Md Rawshan Ai Basunia, MD and Danilo A. Enriquez, MD.

CMS Open Payments shows 8 general payments to Olufemi Aina from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Fresenius USA Marketing, Inc. paid the most, $80.